Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in organoid and animal models, a research team led by Associate Professor Yoshinori Yoshida and Assistant Professor Shunsuke Funakoshi has identified fibroblast growth factor receptor 1 (FGFR1) as a key therapeutic target for cardiac fibrosis in dilated cardiomyopathy (DCM).
This article was originally published on MedicalXpress.com
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
© 2025 SimplyWell.ca